Citations (5)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Alexander J Prokopienko & Thomas D Nolin. (2018) Microbiota-derived uremic retention solutes: perpetrators of altered nonrenal drug clearance in kidney disease. Expert Review of Clinical Pharmacology 11:1, pages 71-82.
Read now
Read now
Articles from other publishers (4)
Jia-Huang Chen & Chih-Kang Chiang. (2021) Uremic Toxins and Protein-Bound Therapeutics in AKI and CKD: Up-to-Date Evidence. Toxins 14:1, pages 8.
Crossref
Crossref
Ping-Hsun Lu, Min-Chien Yu, Meng-Jiun Wei & Ko-Lin Kuo. (2021) The Therapeutic Strategies for Uremic Toxins Control in Chronic Kidney Disease. Toxins 13:8, pages 573.
Crossref
Crossref
Nozomi Yabuuchi, Huixian Hou, Nao Gunda, Yuki Narita, Hirofumi Jono & Hideyuki Saito. (2021) Suppressed Hepatic Production of Indoxyl Sulfate Attenuates Cisplatin-Induced Acute Kidney Injury in Sulfotransferase 1a1-Deficient Mice. International Journal of Molecular Sciences 22:4, pages 1764.
Crossref
Crossref
Esmeralda Castillo-Rodriguez, Raul Fernandez-Prado, Raquel Esteras, Maria Perez-Gomez, Carolina Gracia-Iguacel, Beatriz Fernandez-Fernandez, Mehmet Kanbay, Alberto Tejedor, Alberto Lazaro, Marta Ruiz-Ortega, Emilio Gonzalez-Parra, Ana Sanz, Alberto Ortiz & Maria Sanchez-Niño. (2018) Impact of Altered Intestinal Microbiota on Chronic Kidney Disease Progression. Toxins 10:7, pages 300.
Crossref
Crossref